The Journal of Thoracic and Cardiovascular Surgery
Volume 135, Issue 5 , Pages 1029-1035 , May 2008

Reduced membranous β-catenin protein expression is associated with metastasis and poor prognosis in squamous cell carcinoma of the esophagus

  • Po-Kuei Hsu, MD

      Affiliations

    • Division of Thoracic Surgery, Department of Surgery, Taipei Veterans General Hospital, National Yang-Ming University, School of Medicine, Taipei, Taiwan
    • ,
  • Anna Fen-Yau Li, MD, PhD

      Affiliations

    • Department of Pathology, Taipei Veterans General Hospital, National Yang-Ming University, School of Medicine, Taipei, Taiwan
    • ,
  • Yi-Ching Wang, PhD

      Affiliations

    • Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, Taiwan
    • ,
  • Chih-Cheng Hsieh, MD

      Affiliations

    • Division of Thoracic Surgery, Department of Surgery, Taipei Veterans General Hospital, National Yang-Ming University, School of Medicine, Taipei, Taiwan
    • ,
  • Min-Hsiung Huang, MD

      Affiliations

    • Division of Thoracic Surgery, Department of Surgery, Taipei Veterans General Hospital, National Yang-Ming University, School of Medicine, Taipei, Taiwan
    • ,
  • Wen-Hu Hsu, MD

      Affiliations

    • Division of Thoracic Surgery, Department of Surgery, Taipei Veterans General Hospital, National Yang-Ming University, School of Medicine, Taipei, Taiwan
    • ,
  • Han-Shui Hsu, MD, PhD

      Affiliations

    • Division of Thoracic Surgery, Department of Surgery, Taipei Veterans General Hospital, National Yang-Ming University, School of Medicine, Taipei, Taiwan
    • Corresponding Author InformationAddress for reprints: Han-Shui Hsu, MD, PhD, Division of Thoracic Surgery, Department of Surgery, Taipei Veterans General Hospital, No. 201, Sec. 2, Shih-Pai Road, Taipei, Taiwan.

Received 10 July 2007 ,Revised 29 August 2007 ,Accepted 9 November 2007.

References 

  1. Fahn HJ, Wang LS, Huang BS, Huang MH, Chien KY. Tumor recurrence in long-term survivors after treatment of carcinoma of the esophagus. Ann Thorac Surg. 1994;57:677–681
  2. Doucas H, Garcea G, Neal CP, Manson MM, Berry DP. Changes in the Wnt signaling pathway in gastrointestinal cancers and their prognostic significance. Eur J Cancer. 2005;41:365–379
  3. Nelson WJ, Nusse R. Convergence of Wnt, β-catenin, and cadherin pathways. Science. 2004;303:1483–1487
  4. Ilyas M. Wnt signalling and the mechanistic basis of tumour development. J Pathol. 2005;205:130–144
  5. Moon RT, Kohn AD, De Ferrari GV, Kaykas A. WNT and β-catenin signaling: disease and therapies. Nat Rev Genet. 2004;5:691–701
  6. Ben-Ze'ev A, Geiger B. Differential molecular interaction of β-catenin and plakoglobulin in adhesion, signaling and cancer. Curr Opin Cell Biol. 1998;10:629–639
  7. Prognostic significance of CyclinD1 and E-Cadherin in patients with esophageal squamous cell carcinoma: multiinstitutional retrospective analysis. Research Committee on Malignancy of Esophageal Cancer, Japanese Society for Esophageal Diseases. J Am Coll Surg. 2001;192:708–718
  8. Conacci-Sorrell M, Zhurinsky J, Ben-Ze'ev A. The cadherin–catenin adhesion system in signaling and cancer. J Clin Invest. 2002;109:987–991
  9. Brembeck FH, Rosario M, Birchmeier W. Balancing cell adhesion and Wnt signaling, the key role of β-catenin. Curr Opin Genet Dev. 2006;16:51–59
  10. Damalas A, Ben-Ze'ev A, Simcha I, Shtutman M, Leal JF, Zhurinsjy J, et al. Excess β-catenin promotes accumulation of transcriptionally active p53. EMBO J. 1999;18:3054–3063
  11. Harris SL, Levine AJ. The p53 pathway: positive and negative feedback loops. Oncogene. 2005;24:2899–2908
  12. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell. 1997;88:323–331
  13. Iwai A, Marusawa H, Matsuzawa S, Fukushima T, Hijikata M, Reed JC, et al. Siah-1L, a novel transcript variant belonging to the human Siah family of proteins, regulates β-catenin activity in a p53-dependent manner. Oncogene. 2004;23:7593–7600
  14. Levina E, Oren M, Ben-Ze'ev A. Downregulation of β-catenin by p53 involves changes in the rate of β-catenin phosphorylation and Axin dynamics. Oncogene. 2004;23:4444–4453
  15. Sadot E, Geiger B, Oren M, Ben-Ze'ev A. Down-regulation of ß-catenin by activated p53. Mol Cell Biol. 2001;21:6768–6781
  16. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, et al. AJCC Cancer Staging Manual. 6th ed.. New York: Springer-Verlag; 2002;
  17. de Castro J, Gamallo C, Palacios J, Moreno-Bueno G, Rodriguez N, Feliu J, et al. β-catenin expression pattern in primary oesophageal squamous cell carcinoma. Relationship with clinicopathologic features and clinical outcome. Virchows Arch. 2000;437:599–604
  18. Nair KS, Naidoo R, Chetty R. Microsatellite analysis of the APC gene and immunoexpression of E-cadherin, catenin, and tubulin in esophageal squamous cell carcinoma. Hum Pathol. 2006;37:125–134
  19. Takayama T, Shiozaki H, Shibamoto S, Oka H, Kimura Y, Tamura S, et al. β-catenin expression in human cancers. Am J Pathol. 1996;148:39–46
  20. Nakanishi Y, Ochiai A, Akimoto S, Kato H, Watanabe H, Tachimori Y, et al. Expression of E-cadherin, α-catenin, β-catenin and plakoglobin in esophageal carcinomas and its prognostic significance: immunohistochemical analysis of 96 lesions. Oncology. 1997;54:158–165
  21. Takayama N, Arima S, Haraoka S, Kotho T, Futami K, Iwashita A. Relationship between the expression of adhesion molecules in primary esophageal squamous cell carcinoma and metastatic lymph nodes. Anticancer Res. 2003;23:4435–4442
  22. Zhao XJ, Li H, Chen H, Liu YX, Zhang LH, Liu SX, et al. Expression of E-cadherin and β-catenin in human esophageal squamous cell carcinoma: relationships with prognosis. World J Gastroenterol. 2003;9:225–232
  23. Kang Y, Massague J. Epithelial–mesenchymal transitions: twist in development and metastasis. Cell. 2004;118:277–279
  24. Thiery JP. Epithelial–mesenchymal transitions in tumor progression. Nat Rev Cancer. 2002;2:442–454
  25. Nair KS, Naidoo R, Chetty R. Expression of cell adhesion molecules in esophageal carcinoma and its prognostic value. J Clin Pathol. 2005;58:343–351
  26. Zhang G, Zhou X, Xue L, Quan L, Wang Y, Zhou C, et al. Accumulation of cytoplasmic β-catenin correlates with reduced expression of E-cadherin, but not with phosphorylated Akt in esophageal squamous cell carcinoma: immunohistochemical study. Pathol Int. 2005;55:310–317
  27. Shiozaki H, Doki Y, Kawanishi K, Shamma A, Yano M, Inoue M, et al. Clinical application of malignancy potential grading as a prognostic factor of human esophageal cancers. Surgery. 2000;127:552–561
  28. Yamaguchi M, Hirose F, Inoue YH, Ohno K, Yoshida H, Hayashi Y, et al. Genetic link between p53 and genes required for formation of the zonula adherens junction. Cancer Sci. 2004;95:436–441
  29. Torbenson M, Kannangai R, Abraham S, Sahin F, Choti M, Wang J. Concurrent evaluation of p53, β-catenin, and α-fetoprotein expression in human hepatocellular carcinoma. Am J Clin Pathol. 2004;122:377–382
  30. Nozawa N, Hashimoto S, Nakashima Y, Matsuo Y, Koga T, Sugio K, et al. Immunohistochemical α- and β-catenin and E-cadherin expression and their clinicopathological significance in human lung adenocarcinoma. Pathol Res Pract. 2006;202:639–650

PII: S0022-5223(07)01853-3

doi: 10.1016/j.jtcvs.2007.11.007

The Journal of Thoracic and Cardiovascular Surgery
Volume 135, Issue 5 , Pages 1029-1035 , May 2008

Article Tools

* Image Usage & Resolution